Gabapentin Capsule
Product Images NDC 43353-075

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43353-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 300mg (43353 0075 30)

Gabapentin is a medication produced by Watson Pharma Private Limited in Verna, India. The package comes with 30 capsules, each containing 300mg of gabapentin. The product should be stored between 68-77 degrees Fahrenheit and dispensed as instructed. The NDC number is 43353-0075-30, and the medication was repackaged by Aphena Pharma in Cookeville, TN.*

FDA Label Image

Bottle Label 400mg (43353 0081 60)

Gabapentin is a medication packaged in a bottle containing 90 capsules, with each capsule containing 400mg of the drug. The product has been manufactured by Watson Pharma Private Limited in Verna, India and repackaged by Aphena Pharma in Cookeville, TN 38505. The recommended storage temperature for the drug is between 68-77 degrees Fahrenheit, and the product should be dispensed with a prescription. The product label includes the NDC number 43353-0081-60 and batch number, but no other information about the drug is provided.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

2 (Gabapentin 1)

The text describes a formula to calculate the estimated glomerular filtration rate (eGFR) using the patient's age, weight, and serum creatinine level. The eGFR is a measure of kidney function and is used to diagnose and monitor kidney disease. However, without more context and information on the specific intended use of this formula, the description is too technical to be considered useful for most individuals.*

FDA Label Image

1 (Gabapentin 10)

FDA Label Image

1 (Gabapentin 11)

FDA Label Image

1 (Gabapentin 12)

FDA Label Image

1 (Gabapentin 2)

FDA Label Image

1 (Gabapentin 3)

FDA Label Image

1 (Gabapentin 4)

FDA Label Image

1 (Gabapentin 5)

FDA Label Image

1 (Gabapentin 6)

The text describes a chart showing the mean pain score for a study with a titration period followed by a fixed dose period, comparing a placebo group to a group taking 3600mg/day of Gabapentin. There is also a baseline measurement and the study lasted for four weeks.*

FDA Label Image

2 (Gabapentin 7)

FDA Label Image

3 (Gabapentin 8)

FDA Label Image

4 (Gabapentin 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.